News (All)

Malafi to Receive Girls Inc. of Long Island Butterfly Award

Posted: September 26th, 2016

girls-inc

Campolo, Middleton & McCormick, LLP proudly announces that Girls Inc. of Long Island will honor CMM partner Christine Malafi with a Butterfly Award at the fifth annual awards gala on November 3, 2016.  The event recognizes the exceptional contributions of individuals who exemplify Girls Inc.’s mission to help girls be strong, smart, and bold.  The fundraising event will feature an evening of cocktails, hors d’oeuvres, seated dinner, and dancing to honor industry leaders who inspire girls to spread their wings.  The event will take place at Crest Hollow Country Club at 6:30 p.m.

Malafi was selected for a Butterfly Award for her work on behalf of children and families on Long Island, as well as her dedication to helping girls fulfill their potential.  She is a longtime Girls Inc. volunteer and serves on the Board of the Girl Scouts of Suffolk County.

Malafi chairs the Corporate department at CMM, focusing on mergers and acquisitions, corporate governance, routine and complex transactions and insurance coverage matters.  Malafi was also the first woman and youngest person ever appointed to the position of Suffolk County Attorney, where for eight years she focused on obtaining jury verdicts in favor of the County, enforcing anti-discrimination laws, and protecting children from harm.

Girls Inc. serves girls ages five to 18 in schools and community-based organizations across Long Island.  Annually, the organization provides over 400 girls with life-changing programs, workshops, conferences, and opportunities to learn and grow together.

To register, please visit the registration page.

November 10 – Women Leading Long Island’s East End

Posted: September 25th, 2016

Event Date: November 10th, 2016

women-leading-lis-east-end

Please join us for a panel discussion focusing on the success stories of prominent women who continue to make their mark on Long Island and specifically, the East End. We will host a panel of dynamic women who will share their personal experiences and insights about their rise to the top in their careers.

Panelists include:

Andrea Harum Schiavoni, Southampton Town Justice and Of Counsel at CMM
Maria Baum, CEO at Tracy Anderson Mind & Body
Bridget Fleming, Suffolk County Legislator
Neela Mukherjee Lockel, CEO at American Red Cross on Long Island
Stephanie Bitis, VP/GM, Long Island Radio Broadcasting

AGENDA
8-8:30 a.m. Breakfast & Networking
8:30-9:45 a.m. Panel Discussion
9:45-10 a.m. Q&A

LOCATION
Stony Brook Southampton, Chancellor’s Hall, Duke Lecture Hall
39 Tuckahoe Road, Southampton, NY 11968

This event is free but registration is required. Register here.

The GAO Finds That the EPA Violated Propaganda and Lobbying Provisions Through Its Use of Social Media

Posted: September 21st, 2016

Published In: The Suffolk Lawyer

Tags: ,

Social media’s ubiquitous presence in the lives of many Americans has transformed the way government communicates and interacts with the citizenry.  Nearly every politician, from the President of the United States to mayors of America’s smallest towns, has a Twitter account.  Governments increasingly rely on social media to engage the public, providing information on emergency response and disaster relief to government services and events.  A recent report from the U.S. Government Accountability Office (“GAO”), however, considers when the federal government’s use of social media constitutes impermissible public advocacy in support of an agency’s legislative agenda.  The report raises interesting questions regarding what constitutes government “propaganda” or lobbying efforts in the Internet age.

On December 14, 2015, in response to a request from Senator James M. Inhofe, Chairman of the Senate Committee on Environment and Public Works, the GAO issued a report finding that the Environmental Protection Agency (“EPA”) violated propaganda and anti-lobbying provisions of federal appropriations laws through its use of social media in association with the EPA’s efforts to define “Waters of the United States” under the Clean Water Act (“CWA”).

Federal appropriations bills passed by Congress and signed into law by the President fund the government, including the EPA, and contain any number of restrictions on how those funds may be spent.  Section 718 of the Financial Services and General Government Appropriations Act, for instance, prohibits any appropriation from being used directly or indirectly for “publicity or propaganda purposes” not authorized by Congress.  Section 715 of the Act prohibits indirect or “grassroots” lobbying in support of, or in opposition to, pending legislation.  Section 715 is violated where there is evidence of a clear appeal by an agency to the public to contact Congress.

In March 2014, the EPA released a proposed rule broadening the definition of waters protected under the CWA.  The rule, more popularly referred to as the “Waters of the U.S.” or “WOTUS” rule, expanded the definition to include, among other things, tributaries, adjacent waters, territorial seas, and interstate waters.  The EPA used social media platforms in connection with the WOTUS rulemaking to, by its own admission, clarify issues concerning the proposed rule, explain the benefits of the proposed rule, engage the public, and correct what it viewed as misinformation regarding the rule.  Although the GAO found that certain social media initiatives were lawful, it concluded that the EPA violated federal propaganda and lobbying provisions in two instances.

First, in September 2014, the EPA used Thunderclap, a new “crowd speaking” tool that allows a single message to be shared across multiple social media platforms.   The GAO focused on the fact that the EPA’s Thunderclap message did not identify the Agency as its author.  As the GAO noted, the “critical element of covert propaganda is the agency’s concealment from the target audience of its role in creating the material.”  While the EPA’s authorship was apparent to anyone who chose to follow the EPA’s Thunderclap campaign page, the technology’s force multiplier effect disseminates the message to the followers’ entire social media network.  To that network of contacts, it appeared that their Facebook friend, for instance, independently shared their support for the EPA’s initiative.  The EPA’s message is estimated to have reached upwards of 1.8 million people.

Second, the EPA’s blog associated with WOTUS linked to various third-party advocacy organizations.  The pages to which the EPA linked contained calls for action, encouraging and enabling visitors to contact members of Congress regarding WOTUS-related legislation.  According to the GAO, this violated Section 715’s prohibition against grass-roots lobbying.

The EPA ultimately finalized and published the regulation on June 29, 2015, but cannot currently enforce the rule after the U.S. Court of Appeals for the Sixth Circuit issued a temporary stay.  Dozens of states and business lobbies have brought suit, arguing that the rule represents federal overreach.  The EPA, the Army Corps of Engineers, and the White House maintain that the rule is necessary to protect vulnerable waterways and drinking water.  President Obama has promised to veto any legislation overturning the definition.

The GAO report will likely not impact the pending litigation, nor will it prevent the WOTUS rule from taking effect.  The GAO report, however, does highlight how technology impacts the way in which the Executive and Legislative branches of our government interact with one another and the public, and where one draws the line between advocacy and propaganda in the Internet age.

Fifty years ago, federal agencies could not communicate their position on legislation to the American people with a few clicks of a computer mouse.  Why did the EPA’s actions here cross the line?   It is common practice for a President to spend weeks “stumping” across the country for the policies objectives and legislative proposals contained in his State of the Union address.  Even treating the Presidential bully-pulpit as sui generis and exempted from the grass-roots lobbying restrictions, organizations cannot necessarily control social media campaigns, which, once released, cannot be controlled in the same way as traditional messaging or advocacy.  The answer may turn on the agency’s intent: for instance, whether the agency purposefully used Thunderclap to disguise the source of the message.  We should not be surprised if future appropriations bills may more specifically define how agencies can and cannot use social media.

As was previously reported in the New York Times, the GAO’s finding is rare but not completely without precedent.  During the George W. Bush administration, for instance, the GAO concluded that the Department of Education had violated the law in 2005 when it hired a public relations firm to covertly promote the No Child Left Behind Act.  Federal agencies will need to pay closer attention to how they use social media in connection with pending legislation.  To the extent that state and local governments have similar restrictions, those agencies and instrumentalities must also take warning.

The information contained in this article is provided for informational purposes only and is not and should not be construed as legal advice on any subject matter. The firm provides legal advice and other services only to persons or entities with which it has established an attorney-client relationship.

How to Avoid a “Paper” Anti-Corruption Compliance Program

Posted: September 16th, 2016

Published In: The Suffolk Lawyer

Tags:

In December 2008, Siemens AG, Europe’s largest engineering and electronics conglomerate, settled Foreign Corrupt Practices Act (“FCPA”) charges with the DOJ and SEC for a record-setting $800 million. Aside from the scope of the violations and the size of the penalties, the Siemens case was noteworthy because it so clearly criticized the deficiencies in the company’s compliance program. The DOJ charging papers stated that Siemens merely adopted a “paper program” largely limited to distributing anti-corruption policies without establishing a culture of compliance reinforced by adequate training and controls.

The FCPA prohibits U.S. persons, companies, and issuers from, among other things, bribing or attempting to bribe a foreign official to secure an improper business advantage. As the DOJ and SEC increasingly investigate small and medium-sized companies for potential FCPA violations, the lessons learned from the Siemens settlement are as important today as they were in 2008.  Drafting a comprehensive anti-corruption policy is of little use if it is not enforced, if the company’s compliance personnel are not empowered, or if no one in the organization is trained on how to spot corruption red flags. Companies (and their lawyers), particularly those with significant international operations or overseas sales, must ask themselves whether they too have a “paper” compliance program, assuming they have an anti-corruption program at all.

The following approaches, though not exhaustive, will help ensure that your anti-corruption compliance program is on sure footing and mitigate the damage should your organization face an FCPA investigation.  First, draft an anti-corruption policy that is tailored to your company’s risk, geographic footprint, and other unique considerations. You should not pull an FCPA policy off of a shelf—one size certainly does not fit all. While most anti-corruption policies will contain similar elements, the DOJ and SEC are more impressed with companies that take a risk-based approach to compliance rather than those who simply throw money at the problem and try to emulate what they consider to be a best-in-class compliance program. At the very least, the policy should emphasize a company’s commitment to adhering to both the spirit and letter of the law, as well as explain common FCPA pitfalls, such as travel and entertainment expenses or the role of consultants and agents.

Drafting a sound anti-corruption policy is only the beginning. You need to make sure that employees at all levels are aware of the policy, and that those who represent the greatest FCPA risk are regularly certifying their compliance. Some companies choose to make their anti-corruption policy part of their employee welcome packet. Be careful, however, that the policy is not just another document that everyone has to read and sign. Companies should consider having employees—or at least a subset of high-risk employees—recertify on an annual or semi-annual basis that they have reviewed and understand the policy. Companies should do the same for any overseas consultants or agents.

Next, among the criticisms of Siemen’s compliance efforts was that the company lacked a mandatory FCPA training program. Risk-based and continuous training is a key factor that the DOJ and SEC will consider when evaluating a company’s efforts to comply with the FCPA, and may potentially lessen the consequences of a violation. Training may be in-person, self-led, web-based, or some combination thereof. Moreover, to the extent feasible, companies should tailor their training to the particular audience. For instance, while it may be appropriate to discuss legal standards and concepts when delivering training to the General Counsel’s office, legal jargon is probably not appropriate when delivering the same training to a company’s sales team.

Again, one size does not fit all. Companies should be balancing their resources against their compliance risk. And what do we mean by risk-based? For instance, if a company employs 1,000 people, 900 of whom work in a factory in Oklahoma and 100 work overseas selling and marketing the company’s products to foreign governments, the company should focus its training efforts on those 100 employees who are more likely to deal directly with a foreign official.

The government also criticized Siemens for not appropriately investigating and responding to corruption red flags. Assuming a company has adequately trained its employees, and the policy provides a mechanism for those employees to report suspected corrupt activity, the company must ensure that it responds quickly and effectively. The company must first assess the allegations to determine the scope of the investigation and who should conduct the investigation. Decisions regarding an FCPA investigation should be taken at the highest level possible to ensure accountability.  For instance, the DOJ noted that serious allegations of bribery in the Siemens case were never even referred to the Board of Directors or the Audit Committee. Depending on the circumstances, the Company may not be in a position to investigate the allegations internally and should considering bring in outside counsel to conduct a thorough, impartial investigation.

Finally—although certainly not exhaustively—companies should ensure that their compliance function is adequately resourced and empowered to monitor the anti-corruption program and conduct the due diligence necessary to help prevent FCPA violations in the first place. The DOJ criticized Siemens for failing to establish a “sufficiently empowered and competent” compliance department. The adequacy of compliance resources will vary from organization to organization. After all, a company with 50 employees cannot be expected to spend the same amount of money on compliance as a company with 500 employees. But to the extent possible compliance staff should be independent and, ideally, not dual-hatted. Companies should, on a risk-based standard, conduct due diligence on third-party agents or consultants who operate overseas and potential acquisitions or joint ventures in countries known to have high levels of official corruption.

Anti-corruption compliance means more than drafting a policy or memorandum and sticking it in a drawer. If they hope to avoid FCPA liability, companies and their counsel should be prepared invest the time and resources commensurate with their risk. As the DOJ has been saying for years now, a paper anti-corruption program just doesn’t cut it.

The information contained in this article is provided for informational purposes only and is not and should not be construed as legal advice on any subject matter. The firm provides legal advice and other services only to persons or entities with which it has established an attorney-client relationship.

Rules Governing Collection of Personally Identifiable Information within the EU Set to Change

Posted: August 23rd, 2016

Tags:

Companies that collect personally identifiable information from individuals within the European Union  should be aware of the new General Data Protection Regulations (“GDPR”) approved by the European Parliament earlier this year and effective mid-2018.  The GDPR will replace the current Directive 95/46/EC (“Directive”).  Although implementation is two years away, compliance with the GDPR is onerous.  Businesses should begin to take steps now so that they are fully compliant by the deadline.

The GDPR governs the collection and processing of “personal data,” a term broadly defined to include any data that directly or indirectly identifies a living individual.  This data includes online identifiers, device identifiers, cookie IDs, and IP addresses.  The GDPR applies to businesses that collect personal data as well as those that process personal data.

The conditions for collecting personal data have become stricter.  Businesses must obtain an individual’s consent to use his or her personal data.  The individual must clearly give consent; ways to obtain consent may include the person checking a box when visiting a website or giving the individual the ability to manage technical settings.  The consent must be separately obtained and not a part of a broader agreement addressing other topics.  The services of a business cannot be contingent on obtaining the individual’s consent, unless the business has a legitimate reason for needing the personal data.  The GDPR requires parental consent to collect data for children under 13 years old.

The GDPR requirements related to informing the individual how the personal data is used are more extensive than what the Directive currently requires.  In addition to the requirements under the Directive, businesses must provide individuals with the contact information for the company’s “data protection officer,” the legal basis for processing the data, the details of data transfers outside the EU (if permitted), the duration of retention, the individual’s right to restrict and erase the personal data, and the individual’s right to withdraw consent.

An individual may revoke consent at any time when the processing of personal data is for direct marketing or if there is no legal basis for the collection.  Businesses are required to provide the individual the same methods of withdrawing consent as for obtaining the individual’s consent.  Individuals also have the right to require that the personal data be erased when they revoke their consent.  If an individual revokes consent, the business that collected the personal data must inform other businesses that are using the data.

To reduce the possibility of data breaches, the GDPR subjects businesses to greater data governance obligations.  Some of these obligations include conducting Privacy Impact Assessments, which analyze risks of noncompliance with the GDPR, and appointing a data protection officer, whose duties include advising on compliance and conducting compliance training.  In the event of a data breach, the GDPR provides that all breaches must be reported to the appropriate supervisory authority and possibly the individuals whose personal data was compromised, depending on the severity of the breach.  During and after a breach, businesses must maintain specific documentation and the remedial action taken.

Transfers of personal data to countries outside the EU are restricted unless a safe harbor is in place.  The current safe harbor for transfers to the United States will no longer be valid; however, discussions are ongoing as to implementing a new safe harbor under the GDPR regime.

The penalties for noncompliance with the GDPR are severe.  An individual can bring an action against a business for damages stemming from a violation of the GDPR.  Administrative fines are imposed on a case-by-case basis and can range from €10,000,000 (approximately $11,307,300.00 USD) to €20,000,000 (approximately $22,614,600.00 USD), or 2% to 4% of global turnover, whichever is higher.

If you have any questions regarding the General Data Protections Regulations, please contact us.

The information contained in this article is provided for informational purposes only and is not and should not be construed as legal advice on any subject matter. The firm provides legal advice and other services only to persons or entities with which it has established an attorney-client relationship.

Making Gifts in These Financial Times

Posted: August 23rd, 2016

Tags:

If a person has the desire to make any gifts, now may be a great time to do so.  There are sometimes financial benefits to making certain gifts.  A tough economy is often the best impetus to make gifts.  It may seem counter-intuitive at first—making gifts when the donor has less valuable property—but the conditions are really ripe for the picking.

  1. Interest rates are at historic lows. Low interest rates assist in two major ways.  First, in loan transactions between family members, a lower interest rate can be used without the Internal Revenue Service seeking to impute interest under §7872. The rules for intrafamily loans are a bit complex, so make such loans very carefully.  Second, for certain complex gifting strategies, the Internal Revenue Code requires that the donor compute the gift using rates based on current interest rates.  Since the interest rates are so low, the IRS rates are also very low.
  1. Property values are down. While there has certainly been some rebound, property values are still depressed in many areas, and that will assist in determining the value of the donor’s gift.  There is clearly an emotional component to gifting. So when a potential donor considers making gifts, he or she usually looks to see if he or she will need the asset later.  If the conditions are not so clear, and the potential donor doesn’t feel that he or she can live without that asset, he or she is less likely to give it away.  This is not unusual.  However, emotions aside, the donor can minimize the transfer tax cost by making the gift when the value is low.  This applies with a gift of any type of property, be it real estate, a stock portfolio, artwork, or anything else.
  1. The federal exemption is $5.45 million. Since the federal gift tax exemption is $5.45 million for 2016, up to $5.45 million can be gifted without any federal gift tax.  This exemption permits an immense transfer of wealth without any gift tax consequences.

The combination of low interest rates, lower valuations, and the increased federal gifting exemption are a great combination for gifting.  Many years from now, when we look back on this time, we are likely to see the alignment of these factors as an incredible opportunity to have made substantial gifts.  The only question is: will potential donors take advantage of the opportunity?

The information contained in this article is provided for informational purposes only and is not and should not be construed as legal advice on any subject matter. The firm provides legal advice and other services only to persons or entities with which it has established an attorney-client relationship.

Life Science Companies under Increasing DOJ and SEC Scrutiny for Anti-Corruption Enforcement

Posted: August 23rd, 2016

Tags: , ,

The pharmaceutical and medical device industry has always been among the most heavily regulated in the United States.  In recent years, however, these companies have become the subject of another regulatory and law enforcement focus: the Foreign Corrupt Practices Act (FCPA).

The FCPA is a federal law that prohibits U.S. persons, companies, and issuers from, among other things, bribing or attempting to bribe foreign officials in order to secure an improper business advantage.  The FCPA was passed in 1977, but laid relatively dormant for decades.  In recent years, however, the Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have significantly stepped up enforcement of the FCPA.  For some perspective, since 2008, the top ten FCPA enforcement actions have cost those ten companies a total of $4.4 billion in fines and disgorgement.

Given the frequent interaction with foreign officials, any company operating in a highly regulated or state-controlled industry has an inherently higher risk of one of its employees, consultants, subsidiaries, or partners committing an FCPA violation.  Because the FCPA’s definition of “foreign officials” is so expansive, pharmaceutical and medical device companies are constantly interfacing with such officials.  For instance, in China, most hospitals are state institutions, making doctors and executives foreign officials for the purposes of the FCPA.  The risks are not limited only to the sale of pharmaceutical products to state-owned entities.  Because of the level of government involvement in foreign health markets, the approval, manufacturing, importation, exportation, pricing, and marketing of drugs and medical devices will be subject to government approval at every turn.

Given the inherent risks, it is unsurprising that there has been a marked uptick in DOJ and SEC investigations into the international sales practices of life science companies. Earlier this year, Swiss-based pharmaceutical giant Novartis AG agreed to pay $25 million to the SEC to settle charges that it violated the FCPA when its China-based subsidiaries engaged in pay-to-prescribe schemes to increase sales.  Also in 2016, SciClone Pharmaceuticals paid $12 million to settle claims stemming from international subsidiaries making improper payments to healthcare professionals at state-run institutions in China.  A few years ago, Orthofix International, a Texas-based medical device company, was charged with paying routine bribes referred to as “chocolates” to Mexican officials to obtain sales contracts with government hospitals.  The list goes on and on.

In light of the financial, reputational, and even criminal consequences that come with FCPA violations, pharmaceutical and medical device companies of all sizes must proactively address their anti-corruption compliance needs.  Companies must analyze their international footprint to determine their greatest sources of risk, develop and implement a comprehensive anti-corruption policy, train their relevant staff, consultants, and subsidiaries, and ensure that the company’s culture takes the risks seriously.  Other key initiatives include sound accounting and monitoring practices for all overseas sales, due diligence procedures for engaging third-party consultants or distributors, and clearly-established mechanisms for reporting and investigating potential FCPA violations.  The U.S. government has made it clear that adopting an anti-corruption policy that sits on a shelf collecting dust will not limit your liability—so-called “paper” compliance programs do not suffice.

The information contained in this article is provided for informational purposes only and is not and should not be construed as legal advice on any subject matter. The firm provides legal advice and other services only to persons or entities with which it has established an attorney-client relationship.

Goodwill in Partnership Valuations

Posted: August 23rd, 2016

Published In: The Suffolk Lawyer

Suffolk Lawyer

 

 

Should “goodwill” be a component in in determining the value of a partnership?  The Commercial Division in Albany County recently tackled this issue in the case of Romanoff v. Center for Rheumatology, LLP, et al. (J. Platkin).  The Center for Rheumatology is a medical practice founded in the 1980s and plaintiff Norman Romanoff, M.D. is one of the founding partners.  In late 2013, Dr. Romanoff decided he wanted to retire and sought to dissolve the practice and receive payment for his interest in the practice.  Despite Dr. Romanoff’s attempts to obtain an accounting from his partners, they allegedly refused to comply, so he brought a lawsuit against the practice and the other partners in 2015 under the New York Partnership Law seeking: (1) a valuation and distribution; (2) an accounting; (3) distribution of interest; and (4) winding up of the practice. Before any discovery took place, the defendants, believing the only issue to be determined was whether a value should be placed on the “goodwill” of the partnership, made a motion for summary judgment for a determination on that issue.

In support of their motion, the defendants submitted affidavits from the other partners stating that they never paid any monies toward the goodwill of the practice at any point during the partnership and that Dr. Romanoff was the first partner to leave the practice.  The practice’s accountant also submitted an affidavit claiming that, since he became the accountant in 1993, the practice did not increase the value of goodwill despite the practice’s increase in revenues, profits, and reputation over the years and that the minimal value that was in the practice’s books for goodwill was merely a placeholder.  In opposition, Dr. Romanoff attempted to establish the huge growth of the practice over time, including an additional office, annual revenues over $18 million, increase in employees, increase in services provided, and an extensive professional referral network.  He also provided the affidavit of an accountant who opined that goodwill should be included in valuing Dr. Romanoff’s interest.

The Court, citing Dawson v. White & Case, 88 N.Y.2d 666, 670 (1996), noted in its decision that the term “goodwill,” as it pertains to professional firms, refers to the ability to attract clients as a result of the firm’s name, location, or the reputation of its professionals.  However, “even if a given partnership might be said to possess goodwill, the courts will honor an agreement among partners – whether express or implied – that goodwill not be considered an asset of the [partnership].”  Id. at 671.  In the Dawson case, the Court of Appeals, in finding that the partnership did not assign value to goodwill, specifically relied upon an express agreement among the partners to assign no value to the goodwill of the partnership but also emphasized that the partners’ course of dealing demonstrated that incoming and outgoing partners never paid or received payment for the goodwill of the partnership.

Here, the Court decided that things were still too murky to come to a decision on this issue of “goodwill” so early in the litigation without any discovery.  The Court denied the motion for summary judgment holding that issues of fact remained as to whether the practice has distributable goodwill and whether the practice has the ability to attract patients as a result of its name, location, and reputation.  Importantly, unlike the Dawson case, there was no express agreement among the partners in this case to exclude goodwill as a distributable asset.  The Court also rejected the defendants’ argument that the absence of an express agreement that includes the distribution of goodwill would preclude the plaintiff from obtaining the value of the goodwill because “Goodwill, when it exists as incidental to the business of a partnership, is presumptively an asset to be accounted for.”  Matter of Brown, 242 N.Y. 1, 7 (1926).

The Court did acknowledge that, based on the proof submitted by the defendants, it appeared that there could be an implied agreement among the partners that goodwill would not be considered a distributable asset given their course of dealing and their accounting records.  However, the Court ultimately concluded that, without the benefit of discovery, it was too early to conclusively determine that an implied agreement existed.

Although the Court did not reach a determination one way or the other as to the goodwill of the partnership and whether it is a distributable asset for this practice, this case provides important insight to individuals involved in partnerships as far as what factors courts will consider in reviewing the issue of goodwill as a distributable asset.  As always, if you either want goodwill to be a distributable asset or want it to be excluded, the best approach is always to put it in writing so there can be no doubt as to the parties’ intentions.